ES2148347T3 - Antagonistas del receptor de la bradiquinina pseudo y no peptidica. - Google Patents

Antagonistas del receptor de la bradiquinina pseudo y no peptidica.

Info

Publication number
ES2148347T3
ES2148347T3 ES94929158T ES94929158T ES2148347T3 ES 2148347 T3 ES2148347 T3 ES 2148347T3 ES 94929158 T ES94929158 T ES 94929158T ES 94929158 T ES94929158 T ES 94929158T ES 2148347 T3 ES2148347 T3 ES 2148347T3
Authority
ES
Spain
Prior art keywords
bradykinin
bradiquinine
peptidic
pseudo
receptor antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94929158T
Other languages
English (en)
Inventor
Donald James Kyle
Babu Joseph Mavunkel
Zhijian Lu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scios LLC
Original Assignee
Scios LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/118,550 external-priority patent/US5552383A/en
Priority claimed from US08/281,904 external-priority patent/US5686565A/en
Priority claimed from US08/281,907 external-priority patent/US5541286A/en
Application filed by Scios LLC filed Critical Scios LLC
Application granted granted Critical
Publication of ES2148347T3 publication Critical patent/ES2148347T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/18Kallidins; Bradykinins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

EN LA INVENCION SE PRESENTAN COMPUESTOS ANTAGONISTAS DE LA BRADIQUININA EN DONDE MUCHOS (O TODOS) LOS ENLACES PEPTIDICOS DE BRADIQUININA SE ELIMINAN PARA OBTENER COMPUESTOS QUE COMPITAN ESPECIFICAMENTE CON LA BRADIQUININA PARA ENLAZARSE AL RECEPTOR DE BRADIQUININA. DE MANERA MAS PARTICULAR, LA INVENCION SE REFIERE A COMPUESTOS QUE TIENEN, SEGUN UNA DISPOSICION ESPACIAL APROPIADA, DOS UNIDADES CARGADAS POSITIVAMENTE QUE LINDAN CON UNA UNIDAD ORGANICA HIDROFOBA Y UNA UNIDAD QUE IMITA LA CONFORMACION DE ESPIRAS BETA.
ES94929158T 1993-09-09 1994-09-09 Antagonistas del receptor de la bradiquinina pseudo y no peptidica. Expired - Lifetime ES2148347T3 (es)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US11934193A 1993-09-09 1993-09-09
US11855893A 1993-09-09 1993-09-09
US08/118,550 US5552383A (en) 1992-10-08 1993-09-09 Bradykinin antagonist pseudopeptide derivatives of aminoalkanoic acids and related olefins
US08/118,981 US5444048A (en) 1992-10-08 1993-09-09 Bradykinin antagonist pseudopeptide derivatives of olefinic aminoalkanoic acids
US28190694A 1994-07-28 1994-07-28
US28190894A 1994-07-28 1994-07-28
US08/281,904 US5686565A (en) 1992-10-08 1994-07-28 Bradykinin antagonist pseudopeptide derivatives of aminoalkanoic acids and related olefins
US08/281,907 US5541286A (en) 1992-10-08 1994-07-28 Bradykinin antagonist pseudopeptide derivatives of olefinic aminoalkanoic acids

Publications (1)

Publication Number Publication Date
ES2148347T3 true ES2148347T3 (es) 2000-10-16

Family

ID=27574846

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94929158T Expired - Lifetime ES2148347T3 (es) 1993-09-09 1994-09-09 Antagonistas del receptor de la bradiquinina pseudo y no peptidica.

Country Status (7)

Country Link
EP (1) EP0716661B1 (es)
JP (1) JPH11500100A (es)
AT (1) ATE191486T1 (es)
CA (1) CA2171446C (es)
DE (1) DE69423899T2 (es)
ES (1) ES2148347T3 (es)
WO (1) WO1995007294A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU696429B2 (en) * 1994-03-09 1998-09-10 Cortech, Inc. Bradykinin antagonist peptides incorporating n-substituted glycines
FR2746647B1 (fr) * 1996-03-27 1998-05-15 Oreal Composition apaisante comprenant un extrait d'iridacee
ES2132855T3 (es) * 1995-09-07 1999-08-16 Oreal Extracto de iridaceas y composiciones que lo contienen.
FR2739553B1 (fr) * 1995-10-06 1998-01-02 Oreal Utilisation d'antagonistes de la bradykinine pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
DE19612067A1 (de) * 1996-03-27 1997-10-02 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von chronisch fibrogenetischen Lebererkrankungen und akuten Lebererkrankungen
DE19642289A1 (de) * 1996-10-14 1998-04-16 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung und Prävention der Alzheimer'schen Krankheit
FR2756566B1 (fr) * 1996-12-04 1999-01-08 Fournier Ind & Sante Peptides agonistes du recepteur b2 de la bradykinine, procede de preparation et utilisation en therapeutique
AU8811401A (en) * 2000-09-25 2002-04-02 Toray Industries Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient
US7081463B2 (en) 2002-09-09 2006-07-25 Janssen Pharmaceutica N.V. Hydroxy alkyl substituted 1,3,8-Triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1receptor mediated disorders
WO2005094816A1 (en) 2004-03-11 2005-10-13 Actelion Pharmaceuticals Ltd Indol-1-yl-acetic acid derivatives
RU2387652C2 (ru) 2004-03-11 2010-04-27 Актелион Фармасьютиклз Лтд Производные тетрагидропиридоиндола
CN101052397B (zh) 2004-08-26 2011-07-06 埃科特莱茵药品有限公司 2-硫烷基-苯并咪唑-1-基-乙酸衍生物
CA2974246C (en) * 2006-09-01 2020-02-25 Senhwa Biosciences, Inc. Tricyclic heteroaryl compounds and their use as protein modulators
CN103202840B (zh) 2006-11-28 2015-02-11 詹森药业有限公司 3-(3-氨基-2-(r)-羟基-丙基)-1-(4-氟-苯基)-8-(8-甲基-萘-1-基甲基)-1,3,8-三氮杂-螺[4.5]癸烷-4-酮的盐
RU2338745C1 (ru) * 2007-03-21 2008-11-20 Андрей Александрович Иващенко ЗАМЕЩЕННЫЕ 2,3,4,5-ТЕТРАГИДРО-1Н-ПИРИДО[4,3-b]ИНДОЛЫ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
WO2008124209A1 (en) 2007-04-09 2008-10-16 Janssen Pharmaceutica, N.V. 1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of the orl-i receptor for the treatment of anxiety and depression
WO2009120717A2 (en) 2008-03-24 2009-10-01 Medivation Technologies, Inc. Pyrido [3, 4-b] indoles and methods of use
WO2011038162A1 (en) * 2009-09-23 2011-03-31 Medivation Technologies, Inc. Pyrido(3,4-b)indoles and methods of use
MX2022015207A (es) 2020-06-10 2023-02-13 Aligos Therapeutics Inc Compuestos antivirales para tratar infecciones por coronavirus, picornavirus, y norovirus.
KR20240035513A (ko) 2021-07-09 2024-03-15 알리고스 테라퓨틱스 인코포레이티드 항바이러스 화합물
US12065428B2 (en) 2021-09-17 2024-08-20 Aligos Therapeutics, Inc. Anti-viral compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3428089A (en) * 1988-03-25 1989-10-16 The Administrators Of The Tulane Eductional Fund Therapeutic peptides
EP0618810B1 (en) * 1991-04-19 2001-07-04 Scios Nova Inc. Bradykinin antagonist peptides
US5521158A (en) * 1992-10-08 1996-05-28 Scios Nova Inc. Pseudopeptide bradykinin receptor antagonists

Also Published As

Publication number Publication date
EP0716661B1 (en) 2000-04-05
EP0716661A1 (en) 1996-06-19
ATE191486T1 (de) 2000-04-15
DE69423899T2 (de) 2000-11-09
JPH11500100A (ja) 1999-01-06
DE69423899D1 (de) 2000-05-11
CA2171446A1 (en) 1995-03-16
CA2171446C (en) 2004-11-23
WO1995007294A1 (en) 1995-03-16

Similar Documents

Publication Publication Date Title
ES2148347T3 (es) Antagonistas del receptor de la bradiquinina pseudo y no peptidica.
TR199701526T1 (xx) Bir trombopoietin resept�r�ne ba�lanan peptitler ve bile�ikler.
MX9703186A (es) Antagonistas del receptor del neuropeptido y de indolilo.
DK0610743T3 (da) Immunsuppressive aminoethylen-peptider
WO2001016114A3 (en) Heterocyclic compounds and methods for modulating cxcr3 function
BR9408063A (pt) Antagonistas de receptores de taquicinina que nÆo sÆo pept¡deos
WO1996006108A3 (en) Cyclic cs-1 peptidomimetics, compositions and methods of using the same
TR200200785T2 (tr) 8-Fenil-6,9-dihidro-[1,2,4] triazolo [3,4-i] purin-5-on türevleri
DE69426033D1 (de) Für die alpha-1e untereinheit des menschlichen kalziumkanals kodierende dna
HU9603312D0 (en) Novel elastase inhibitors
AU634280B2 (en) Anticoagulant peptides
CA2286296A1 (en) Inhibitors for urokinase receptor
CA2004885A1 (en) Anticoagulant peptides
FI922720A0 (fi) Farmakologiskt aktiva amidkarboxylatderivat.
GR3021660T3 (en) Anticoagulant peptides
FI943359L (fi) Atsasykliset-heterosykliset yhdisteet angiotensiini II reseptoriantagonisteina
AU2280895A (en) Synthesis n-protected amino acids, especially n-boc-l-propargylglycine by zinc-mediated addition or organic halides to glycine cation equivalent
ATE165594T1 (de) Triarylethylenderivate zur therapeutischen verwendung
GB2335984B (en) Genetic test for equine severe combined immunodeficiency disease
FI941118A0 (fi) Bentsyyli-imidatsopyridiinijohdannainen angiotensiini II reseptoriantagonistina
DE69733026D1 (de) Cyclin e spezifische konstrukte und komplexe
TW282449B (es)
ITTO940423A0 (it) Macchina per la raccolta di olive dal suolo.
IT8741634A0 (it) Calzatura con mezzi elastici ausiliari di serraggio.
KR950002175U (ko) 편향요크의 코마프리 보정편 이송장치

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 716661

Country of ref document: ES